• ๐ŸŒŽ Worldwide
    • ๐Ÿ‡บ๐Ÿ‡ธ U.S.
    • ๐Ÿ‡จ๐Ÿ‡ฆ Canada
    • ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
    • ๐ŸŒ Asia
    • ๐ŸŒ Europe
    • ๐ŸŒŽ Latin America
    • ๐ŸŒ Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Investments Marijuana Stocks

Canntab Awarded Health Canada Cannabis Research Licence

Canntab Therapeutics intends to develop hard pill oral delivery formulations...

PR Newswire by PR Newswire
February 24, 2020
in Canada, Investments, Marijuana Stocks, Press Releases
Neptune Obtains Health Canada Authorization and is Fast Tracking FDA Registration to Commercialize Plant-Based Hand Sanitizers
31
SHARES
ShareShare

TORONTO,ย Feb. 24, 2020ย /PRNewswire/ – Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab”), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, is pleased to announce that Health Canada has granted the Company a Cannabis Research Licence for the purpose of continuing research and development of the Company’s growing line of next generation medical cannabis solutions at the Company’s Markham Ontario Facility.

Canntab intends, following receipt of a Standard Processing Licence and Sale for Medical Purposes Licence ย from Health Canada (the “Additional Licences”), to produce various hard pill oral delivery formulations including extended release, instant release, and bi-layered hard pills that provide patients and practitioners with a highly bioavailable medical solution with accurate dosing. The Additional Licences will enable Canntab to submit Notice of New Cannabis Products (NNCP) to Health Canada.

“Our Cannabis Research Licence will allow us to be prepared for when we receive our Standard Processing Licence and Sale” for Medical Purposes Licence, which we expect to receive shortly, by allowing us to do research and testing.ย  Once we obtain our Standard Processing Licence and Sale for Medical Purposes Licence, we will have products ready for distribution and sale, explainsย Jeff Renwick, co-founder and CEO of Canntab. Mr. Renwick continues, “our facility is fully built-out and we are excited to prepare our final formulations for submission. We are equally excited with the prospect of continuing research and development in full force at ourย Markhamย facility, beginning with our proprietary Oral Dissolvable Tablet formulations which enter through the buccal cavity in the patient’s mouth.”

About Canntab Therapeutics

Canntab Therapeutics Ltd. is a Canadian company with operations inย Canada. ย Canntab has also established a wholly owned US subsidiary through which we will operate our business inย the United States. Upon our receipt of LP Status from Health Canada, Canntab will begin full-scale manufacturing of its suite of precision oral dose products that are unavailable elsewhere in the marketplace, namely, formulations in multiple doses and time release combinations. Additionally, Canntab through its wholly owned American subsidiary operate Canntab’s manufacturing and distribution business inย the United States, with the Company’s partner Exactus Inc.

Canntab’s proprietary hard pill medical cannabis formulations will provide doctors, patients and consumers with medical grade solutions which incorporate all the features one would expect from any prescription or over the counter medication sold in Canadian pharmacies.

Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1.

Cautionary Statements

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or negatives of these terms and similar expressions. Forward-looking statements are based on certain assumptions, including successful receipt of the Additional Licences, the approval by Health Canada of the Company’s Notice of New Cannabis Products, and general business, economic, competitive, political and social uncertainties will not prevent the Company from conducting its business.ย  While Canntab considers these assumptions to be reasonable, based on information currently available, they are inherently subject to significant business, economic and competitive uncertainties and contingencies and they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements also necessarily involve known and unknown risks, including without limitation, risks associated with Health Canada not approving the Company’s application for a new licence or Notice of New Cannabis Products, general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory developments, the inability to access sufficient capital on favourable terms, the medical and recreational cannabis industry inย Canadaย in general, income tax and regulatory matters, the ability of Canntab to execute its business strategies, competition, crop failure, currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ from those anticipated. Forward-looking statements are not guarantees of future performance. Except as required by law, Canntab disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. Forward- looking statements contained in this news release are expressly qualified by this cautionary statement.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: Cannabis Research LicenceCanntab Therapeutics LimitedCSE:PILLFRA:TBF1Health Canadalicensed producerOTC:CTABF

Get Real-Time Updates from MJobserver.com

Unsubscribe
PR Newswire

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.

Related Posts

INDIVA Ltd. (TSXV: NDVA) (OTC: NDVAF) Cannabis Stock News
Ontario

Indiva Reports Record Market Share for January 2021

February 9, 2021
HEXO Corp. Marijuana Stock
Press Releases

HEXO Corp Appoints General Manager of US Operations

February 8, 2021
Piper Jaffray - Marijuana Stocks News
Investments

Piper Sandler Downgrades Canopy Growth Corp.

February 5, 2021
Delta 9 Announces Two Locations for Cannabis Retail Stores in Manitoba
Manitoba

Delta 9 to Open Tenth Cannabis Retail Store

February 5, 2021
Health Canada Licensed Cannabis Producer and Processor Stocks
Press Releases

GCAC Announces Health Canada Medical Cannabis Sales License

February 4, 2021
Cannabis Stocks Targeting Spain and Europe
Spain

Tilrayยฎ Exports First Shipment of Medical Cannabis to Spain

February 4, 2021
Load More
Next Post
MJardin Group, Inc. Cannabis Stock News

MJardin Receives Health Canada Approval for Amendment of Ontario Facility

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

๐Ÿšจ Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

โœ‰๏ธ Subscribe to Our Newsletter!

* indicates required

๐Ÿ”Ž Search Marijuana Stocks

๐Ÿ“ฐ Recent News

  • Verano Holdings Enters into Agreement to Expand Arizona Footprint
  • Green Thumb Industries Announces Initial Public Offering in the U.S. to Raise US$100,000,000
  • Greenlane Announces Dismissal of Remaining Securities Class Action
  • Indiva Reports Record Market Share for January 2021
  • Acreage Announces Fourth Quarter And Full Year 2020 Earnings Date
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • ๐Ÿ‡บ๐Ÿ‡ธ United States
  • ๐Ÿ‡จ๐Ÿ‡ฆ Canada
  • ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
  • ๐ŸŒ Asia
  • ๐ŸŒ Europe
  • ๐ŸŒŽ Latin America
  • ๐ŸŒ Oceania and Australasia

Cannabis Tools & Resources

  • ๐Ÿ“… Calendar
  • ๐Ÿ“Š Databases
  • ๐Ÿ“‡ Directories
  • ๐Ÿ”” RSS Feeds
  • ๐Ÿ“บ Videos

Find Cannabis Business Services

  • โš–๏ธ Attorneys & Law Firms
  • ๐Ÿ“Š Accountants & Accounting Firms
  • ๐Ÿ’ก Consultants & Consulting Firms
  • ๐Ÿ“ฒ Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • ๐Ÿ‘€ Advertise
  • ๐Ÿ“ฃ DMO Newswire
  • ๐Ÿ“‡ List in Our Databases

ยฉ 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerโ„ข (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • ๐Ÿ”’ PRO
    • ๐Ÿ”’ A.M. Watchlist
    • ๐Ÿ”’ Analyst Action
  • ๐Ÿ’ผ Business
  • ๐Ÿ“ˆ Investments
    • ๐Ÿ“ˆ Stocks
    • ๐Ÿ’ฐ ETFs and Funds
    • ๐Ÿ’ญ Market Commentary
    • ๐Ÿ“ฐ Press Releases
    • ๐Ÿ“… Earnings Calendar
  • โš–๏ธ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • ๐Ÿ‘ฅ People
    • โšฝ Athletes
    • ๐Ÿ’ผ Executives
    • ๐ŸŒŸ Celebrities
    • ๐Ÿ›’ Consumers
    • โš•๏ธ Doctors
    • ๐Ÿ’Š Patients
  • ๐Ÿ’Š Health
  • ๐Ÿ“‡ Databases
    • ๐Ÿ“ˆ Stock Databases
    • ๐Ÿ’ฐ Fund Databases
    • ๐Ÿ’ผ Service Providers Databases
    • ๐Ÿฆ Marijuana Stock Brokers
    • ๐Ÿ’ฒ Marijuana Cryptocurrencies

ยฉ 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerโ„ข (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.